Testing effectiveness (Phase 2)Study completedNCT01748539What this trial is testingClinical Study of KHK4827Who this might be right forModerate to Severe Plaque Psoriasis Kyowa Kirin Co., Ltd. 140
Early research (Phase 1)Study completedNCT01836939What this trial is testingSafety and Effectiveness of CNDO 201Trichuris Suis Ova (TSO) for the Treatment of Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Mark Lebwohl 8
Testing effectiveness (Phase 2)Study completedNCT02223039What this trial is testingMultiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forModerate to Severe Chronic Plaque Psoriasis AbGenomics B.V Taiwan Branch 50
Testing effectiveness (Phase 2)Ended earlyNCT05044234What this trial is testingAssess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe PsoriasisWho this might be right forPsoriasis AbbVie 156
Large-scale testing (Phase 3)Active Not RecruitingNCT06220604What this trial is testingJNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)Who this might be right forPlaque Psoriasis Janssen Research & Development, LLC 731
Large-scale testing (Phase 3)Study completedNCT03504852What this trial is testingEfficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque PsoriasisWho this might be right forModerate to Severe Chronic Plaque-type Psoriasis Novartis Pharmaceuticals 331
Not applicableStudy completedNCT04203693What this trial is testingObservational Study of Tildrakizumab in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical PracticeWho this might be right forPlaque Psoriasis Almirall, S.A. 331
Testing effectiveness (Phase 2)Study completedNCT00320216What this trial is testingA Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Centocor, Inc. 320
Testing effectiveness (Phase 2)Ended earlyNCT03835481What this trial is testingTest How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it isWho this might be right forPsoriasis Boehringer Ingelheim 165
Testing effectiveness (Phase 2)Study completedNCT07707141What this trial is testingSafety and Efficacy of HPP737 in Adult Patients With Plaque PsoriasisWho this might be right forPsoriasis Newsoara Biopharma Co., Ltd. 123
Large-scale testing (Phase 3)Looking for participantsNCT04772079What this trial is testingEvaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Bristol-Myers Squibb 153
Large-scale testing (Phase 3)Study completedNCT05073315What this trial is testingA Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Amgen 425
Testing effectiveness (Phase 2)Study completedNCT03421197What this trial is testingAssess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate)Who this might be right forPsoriasis Dr. Reddy's Laboratories Limited 426
Testing effectiveness (Phase 2)Study completedNCT00808223What this trial is testingSafety and Pharmacokinetics (PK) of Alefacept in Adolescent Subjects With Moderate to Severe PsoriasisWho this might be right forPsoriasis Astellas Pharma Inc 30
Post-approval studies (Phase 4)Study completedNCT01644396What this trial is testingAn Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian FederationWho this might be right forModerate to Severe Plaque Psoriasis AbbVie (prior sponsor, Abbott) 50
Large-scale testing (Phase 3)WithdrawnNCT02795416What this trial is testingAssessment of Efficacy and Safety of Secukinumab in Adult Patients in Turkish PopulationWho this might be right forPsoriasis Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT06398652What this trial is testingComparative Study of CMAB015 and Secukinumab for Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Taizhou Mabtech Pharmaceutical Co.,Ltd 336
Not applicableStudy completedNCT04818385What this trial is testingStudy to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in TaiwanWho this might be right forPsoriasis AbbVie 240
Large-scale testing (Phase 3)Study completedNCT02951533What this trial is testingCompare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Janssen-Cilag G.m.b.H 119
Testing effectiveness (Phase 2)Study completedNCT04172233What this trial is testingA Clinical Study of AK101 in Subjects With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Akeso 96